tiprankstipranks
Blurbs

Analysts Offer Insights on Healthcare Companies: Brickell Biotech (BBI), Phio Pharmaceuticals (PHIO) and Albireo Pharma (ALBO)

There’s a lot to be optimistic about in the Healthcare sector as 3 analysts just weighed in on Brickell Biotech (BBIResearch Report), Phio Pharmaceuticals (PHIOResearch Report) and Albireo Pharma (ALBOResearch Report) with bullish sentiments.

Brickell Biotech (BBI)

H.C. Wainwright analyst Ram Selvaraju reiterated a Buy rating on Brickell Biotech today and set a price target of $4.50. The company’s shares closed last Monday at $3.50, close to its 52-week low of $2.88.

According to TipRanks.com, Selvaraju has currently 0 stars on a ranking scale of 0-5 stars, with an average return of -29.0% and a 24.8% success rate. Selvaraju covers the Healthcare sector, focusing on stocks such as Santhera Pharmaceuticals Holding AG, MoonLake Immunotherapeutics, and Aquestive Therapeutics.

Brickell Biotech has an analyst consensus of Moderate Buy, with a price target consensus of $4.50.

See Insiders’ Hot Stocks on TipRanks >>

Phio Pharmaceuticals (PHIO)

In a report released today, Vernon Bernardino from H.C. Wainwright reiterated a Buy rating on Phio Pharmaceuticals, with a price target of $6.00. The company’s shares closed last Monday at $0.76, close to its 52-week low of $0.62.

According to TipRanks.com, Bernardino is a 5-star analyst with an average return of 26.7% and a 37.7% success rate. Bernardino covers the Healthcare sector, focusing on stocks such as Finch Therapeutics Group, Aridis Pharmaceuticals, and Eledon Pharmaceuticals.

The word on The Street in general, suggests a Moderate Buy analyst consensus rating for Phio Pharmaceuticals with a $6.00 average price target.

Albireo Pharma (ALBO)

In a report released today, Ed Arce from H.C. Wainwright maintained a Buy rating on Albireo Pharma, with a price target of $54.00. The company’s shares closed last Monday at $24.93.

According to TipRanks.com, Arce is a 4-star analyst with an average return of 8.8% and a 40.3% success rate. Arce covers the Healthcare sector, focusing on stocks such as Madrigal Pharmaceuticals, Paratek Pharmaceuticals, and Aurinia Pharmaceuticals.

Albireo Pharma has an analyst consensus of Strong Buy, with a price target consensus of $63.00.

TipRanks has tracked 36,000 company insiders and found that a few of them are better than others when it comes to timing their transactions. See which 3 stocks are most likely to make moves following their insider activities.

Read More on BBI:

Tired of arriving late to the Big Returns Party?​
Most investors don’t have major gainers like TSLA or NVDA on their radar from the start.
The profusion of opinions on social media and financial blogs makes it impossible to distinguish between real growth potential and pure hype.
​​For the past decade, we have developed and perfected technology designed to help private investors, just like you, find the best opportunities, with the greatest upside potential, in any financial climate.​
Learn More